Robert E. Landry

Chief Financial Officer, Regeneron Pharmaceuticals.

Companies

ZymeworksBoard member Aug 12, 2025 to now¹
CytokineticsBoard member Feb 11, 2025 to now²
Regeneron PharmaceuticalsChief financial officer Sep 11, 2013 to Feb 6, 2024³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZymeworks, Board member
2
SEC EDGARCytokinetics, Board member
3
SEC EDGARRegeneron Pharmaceuticals, Chief financial officer